People · Operator
Named in public records as an officer, director or promoter · active 2018–2018 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Chase Therapeutics Corp | — | Pharmaceuticals | Seed | $5.3M | $152.2M | 2018 |
John P. Reher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John P. Reher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thomas N. Chase | 1 | 2 |
| Richard P. Dulik | 1 | 2 |
| Kathleen N. Clarence-Smith | 1 | 2 |
| Karoly P. Nikolich | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.